sulfinpyrazone has been researched along with reserpine in 9 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 6 (66.67) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (11.11) | 29.6817 |
2010's | 2 (22.22) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Artursson, P; Bergström, CA; Hoogstraate, J; Matsson, P; Norinder, U; Pedersen, JM | 1 |
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
Chen, X; Lin, X; Skolnik, S; Wang, J | 1 |
Cazenave, JP; Guccione, MA; Mustard, JF; Packham, MA | 1 |
Heptinstall, RH; Hill, GS; Murray, G; Ramsden, PW; Wyllie, RG | 1 |
Douglas, AS | 1 |
Deuticke, B | 1 |
Mason, RG; Read, MS; Saba, SR; Shermer, RW | 1 |
Chignard, M; Lefort, J; Medeiros, MC; Vargaftig, BB; Wal, F | 1 |
2 review(s) available for sulfinpyrazone and reserpine
Article | Year |
---|---|
Management of thrombotic diseases.
Topics: Anticoagulants; Aspirin; Blood Coagulation; Blood Platelets; Cerebrovascular Disorders; Coronary Disease; Coumarins; Dextrans; Dipyridamole; Drug Antagonism; Drug Hypersensitivity; Fibrinogen; Fibrinolysis; Fibrinolytic Agents; Heart Valve Prosthesis; Hemorrhage; Heparin; Histamine H1 Antagonists; Humans; Hydrocortisone; Indenes; Intracranial Embolism and Thrombosis; Iodine Isotopes; Platelet Adhesiveness; Prostaglandins; Reserpine; Rheumatic Heart Disease; Streptokinase; Sulfinpyrazone; Thrombosis | 1971 |
Anion permeability of the red blood cell.
Topics: Benzoates; Biological Transport; Caprylates; Cell Membrane Permeability; Dicarboxylic Acids; Diffusion; Dinitrophenols; Dipyridamole; Erythrocytes; Gentisates; Hydrogen-Ion Concentration; Hydroquinones; Osmolar Concentration; Phenylbutazone; Phloretin; Phlorhizin; Phosphates; Quaternary Ammonium Compounds; Reserpine; Resorcinols; Salicylates; Sulfates; Sulfinpyrazone; Vasodilator Agents | 1970 |
7 other study(ies) available for sulfinpyrazone and reserpine
Article | Year |
---|---|
Prediction and identification of drug interactions with the human ATP-binding cassette transporter multidrug-resistance associated protein 2 (MRP2; ABCC2).
Topics: Administration, Oral; Animals; Antineoplastic Agents; Antipsychotic Agents; Antiviral Agents; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 1; ATP Binding Cassette Transporter, Subfamily G, Member 2; ATP-Binding Cassette Transporters; Biological Transport; Cell Line; Computer Simulation; Cytochrome P-450 Enzyme System; Drug-Related Side Effects and Adverse Reactions; Estradiol; Humans; Insecta; Liver; Models, Molecular; Multidrug Resistance-Associated Protein 2; Multidrug Resistance-Associated Proteins; Neoplasm Proteins; Pharmaceutical Preparations; Pharmacology; Structure-Activity Relationship | 2008 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Attenuation of intestinal absorption by major efflux transporters: quantitative tools and strategies using a Caco-2 model.
Topics: Adenosine; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily G, Member 2; ATP-Binding Cassette Sub-Family B Member 4; ATP-Binding Cassette Transporters; Biological Transport; Caco-2 Cells; Chromatography, Liquid; Dibenzocycloheptenes; Diketopiperazines; Drug Discovery; Heterocyclic Compounds, 4 or More Rings; Humans; Intestinal Absorption; Mass Spectrometry; Models, Biological; Neoplasm Proteins; Pharmaceutical Preparations; Predictive Value of Tests; Propionates; Quinolines; Substrate Specificity | 2011 |
Inhibition of platelet adherence to damaged vessel wall by drugs.
Topics: Animals; Aorta; Aspirin; Cephalothin; Depression, Chemical; In Vitro Techniques; Penicillin G; Platelet Adhesiveness; Rabbits; Reserpine; Sulfinpyrazone | 1977 |
Experimental papillary necrosis of the kidney. 3. Effects of reserpine and other pharmacologic agents on the lesion.
Topics: Adenosine Triphosphatases; Animals; Blood Pressure; Bromine; Catecholamines; Chlorpromazine; Coloring Agents; Disease Models, Animal; Dopamine; Ethylamines; Female; Heparin; Histocytochemistry; Kidney; Kidney Papillary Necrosis; L-Lactate Dehydrogenase; Microscopy, Electron; Phenoxybenzamine; Rats; Rats, Inbred Strains; Reserpine; Staining and Labeling; Sulfinpyrazone | 1972 |
Apparent similarity of mechanisms of platelet adhesion and aggregation. Differentiation of these functions from clot retraction.
Topics: Amitriptyline; Aspirin; Blood Coagulation Tests; Caffeine; Chloromercuribenzoates; Chlorpromazine; Clot Retraction; Cocaine; Diphenhydramine; Ethacrynic Acid; Guanidines; Humans; Phenothiazines; Phentolamine; Phenylbutazone; Platelet Adhesiveness; Promethazine; Quinacrine; Quinidine; Reserpine; Sulfinpyrazone; Sulfones; Tosyl Compounds | 1972 |
Pharmacological properties of PAF-acether in the guinea-pig: platelet-dependent and independent reactions.
Topics: Animals; Blood Platelets; Bronchi; Guinea Pigs; Platelet Activating Factor; Platelet Aggregation; Reserpine; Stereoisomerism; Sulfinpyrazone | 1982 |